Clinical results of using a high-repetition-rate excimer laser with an optimized ablation profile for myopic correction in 10 235 eyes.
To evaluate the visual outcomes, safety, stability, efficacy, and predictability of laser in situ keratomileusis (LASIK) to correct myopia using a high-repetition-rate excimer laser with an optimized ablation profile. Private clinic, Tokyo, Japan. Retrospective noncomparative study. In this study, patients had LASIK using the Schwind Amaris excimer laser for myopic correction. The study comprised 10 235 eyes of 5191 patients. The patients' mean age was 33.9 years ± 7.84 (SD) (range 18 to 56 years). The mean preoperative manifest refraction spherical equivalent (MRSE) was -5.02 ± 2.17 diopters (D) (range -2.75 to -11.50 D). Three months postoperatively, 82.0% of patients achieved an uncorrected distance visual acuity of -0.18 logMAR or better and 96.9% achieved 0.00 logMAR or better. The MRSE was within ±0.50 D of the intended refractive target in 88.4% of eyes and within ±1.00 D in 98.8%. Despite using the profile designed to minimize postoperative aberrations, the postoperative corneal and ocular higher-order aberrations increased. Laser in situ keratomileusis using a high-repetition-rate excimer laser was a safe and effective procedure, yielding predictable results for a wide range of myopic patients. Mr. Magnago is an employee of Schwind Eye-Tech Solutions GmbH & Co. KG. No other author has a financial or proprietary interest in any material or method mentioned.